nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—Mitiglinide—Nelfinavir—acquired immunodeficiency syndrome	0.188	0.569	CrCrCtD
Nateglinide—Mitiglinide—Saquinavir—acquired immunodeficiency syndrome	0.142	0.431	CrCrCtD
Nateglinide—ALB—acquired immunodeficiency syndrome	0.133	1	CbGaD
Nateglinide—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0236	0.0559	CbGbCtD
Nateglinide—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0215	0.0511	CbGbCtD
Nateglinide—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0198	0.047	CbGbCtD
Nateglinide—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0179	0.0423	CbGbCtD
Nateglinide—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0167	0.0395	CbGbCtD
Nateglinide—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0118	0.0279	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0118	0.0279	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0102	0.0241	CbGbCtD
Nateglinide—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0102	0.0241	CbGbCtD
Nateglinide—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00987	0.0234	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00987	0.0234	CbGbCtD
Nateglinide—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00977	0.0232	CbGbCtD
Nateglinide—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.00938	0.0222	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00893	0.0212	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00893	0.0212	CbGbCtD
Nateglinide—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00893	0.0212	CbGbCtD
Nateglinide—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00893	0.0212	CbGbCtD
Nateglinide—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00884	0.021	CbGbCtD
Nateglinide—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00884	0.021	CbGbCtD
Nateglinide—ALB—Saquinavir—acquired immunodeficiency syndrome	0.00833	0.0198	CbGbCtD
Nateglinide—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00799	0.0189	CbGbCtD
Nateglinide—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00763	0.0181	CbGbCtD
Nateglinide—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0074	0.0176	CbGbCtD
Nateglinide—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00725	0.0172	CbGbCtD
Nateglinide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00697	0.0165	CbGbCtD
Nateglinide—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0067	0.0159	CbGbCtD
Nateglinide—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0067	0.0159	CbGbCtD
Nateglinide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00655	0.0155	CbGbCtD
Nateglinide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00655	0.0155	CbGbCtD
Nateglinide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00637	0.0151	CbGbCtD
Nateglinide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00599	0.0142	CbGbCtD
Nateglinide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00599	0.0142	CbGbCtD
Nateglinide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00593	0.0141	CbGbCtD
Nateglinide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00593	0.0141	CbGbCtD
Nateglinide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00542	0.0129	CbGbCtD
Nateglinide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00542	0.0129	CbGbCtD
Nateglinide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00511	0.0121	CbGbCtD
Nateglinide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00497	0.0118	CbGbCtD
Nateglinide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00468	0.0111	CbGbCtD
Nateglinide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00454	0.0108	CbGbCtD
Nateglinide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00449	0.0107	CbGbCtD
Nateglinide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00449	0.0107	CbGbCtD
Nateglinide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00431	0.0102	CbGbCtD
Nateglinide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00411	0.00974	CbGbCtD
Nateglinide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00411	0.00974	CbGbCtD
Nateglinide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00405	0.00961	CbGbCtD
Nateglinide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00381	0.00904	CbGbCtD
Nateglinide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00381	0.00904	CbGbCtD
Nateglinide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00345	0.00817	CbGbCtD
Nateglinide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00345	0.00817	CbGbCtD
Nateglinide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00297	0.00705	CbGbCtD
Nateglinide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00289	0.00685	CbGbCtD
Nateglinide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00261	0.00619	CbGbCtD
Nateglinide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00261	0.00619	CbGbCtD
Nateglinide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0025	0.00594	CbGbCtD
Nateglinide—ORM1—saliva—acquired immunodeficiency syndrome	0.00202	0.0751	CbGeAlD
Nateglinide—Amphetamine—CARTPT—acquired immunodeficiency syndrome	0.00131	0.522	CrCbGaD
Nateglinide—L-Phenylalanine—TAT—acquired immunodeficiency syndrome	0.0012	0.478	CrCbGaD
Nateglinide—PPARG—endothelium—acquired immunodeficiency syndrome	0.000924	0.0344	CbGeAlD
Nateglinide—PPARG—blood plasma—acquired immunodeficiency syndrome	0.000821	0.0306	CbGeAlD
Nateglinide—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.000745	0.0278	CbGeAlD
Nateglinide—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.000641	0.0239	CbGeAlD
Nateglinide—SLC16A1—retina—acquired immunodeficiency syndrome	0.000536	0.02	CbGeAlD
Nateglinide—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000494	0.0184	CbGeAlD
Nateglinide—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000488	0.0182	CbGeAlD
Nateglinide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00048	0.0179	CbGeAlD
Nateglinide—KCNJ11—lymphoid tissue—acquired immunodeficiency syndrome	0.000454	0.0169	CbGeAlD
Nateglinide—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000439	0.0163	CbGeAlD
Nateglinide—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000395	0.0147	CbGeAlD
Nateglinide—PPARG—skin of body—acquired immunodeficiency syndrome	0.000394	0.0147	CbGeAlD
Nateglinide—ABCC8—spinal cord—acquired immunodeficiency syndrome	0.000379	0.0141	CbGeAlD
Nateglinide—SLC16A1—digestive system—acquired immunodeficiency syndrome	0.000376	0.014	CbGeAlD
Nateglinide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000366	0.0136	CbGeAlD
Nateglinide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000361	0.0134	CbGeAlD
Nateglinide—SLC15A2—retina—acquired immunodeficiency syndrome	0.000352	0.0131	CbGeAlD
Nateglinide—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000349	0.013	CbGeAlD
Nateglinide—KCNJ11—nervous system—acquired immunodeficiency syndrome	0.000347	0.0129	CbGeAlD
Nateglinide—SLC16A1—spinal cord—acquired immunodeficiency syndrome	0.000345	0.0129	CbGeAlD
Nateglinide—KCNJ11—central nervous system—acquired immunodeficiency syndrome	0.000334	0.0124	CbGeAlD
Nateglinide—ORM1—blood—acquired immunodeficiency syndrome	0.000322	0.012	CbGeAlD
Nateglinide—ABCC8—nervous system—acquired immunodeficiency syndrome	0.00032	0.0119	CbGeAlD
Nateglinide—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.000319	0.0119	CbGeAlD
Nateglinide—PPARG—digestive system—acquired immunodeficiency syndrome	0.000316	0.0118	CbGeAlD
Nateglinide—SLC16A1—lung—acquired immunodeficiency syndrome	0.000314	0.0117	CbGeAlD
Nateglinide—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000311	0.0116	CbGeAlD
Nateglinide—ORM1—spinal cord—acquired immunodeficiency syndrome	0.00031	0.0115	CbGeAlD
Nateglinide—ABCC8—central nervous system—acquired immunodeficiency syndrome	0.000308	0.0115	CbGeAlD
Nateglinide—PPARG—blood—acquired immunodeficiency syndrome	0.000301	0.0112	CbGeAlD
Nateglinide—PPARG—bone marrow—acquired immunodeficiency syndrome	0.000291	0.0108	CbGeAlD
Nateglinide—SLC16A1—nervous system—acquired immunodeficiency syndrome	0.000291	0.0108	CbGeAlD
Nateglinide—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000287	0.0107	CbGeAlD
Nateglinide—ORM1—lung—acquired immunodeficiency syndrome	0.000282	0.0105	CbGeAlD
Nateglinide—SLC22A6—brain—acquired immunodeficiency syndrome	0.000281	0.0105	CbGeAlD
Nateglinide—SLC16A1—central nervous system—acquired immunodeficiency syndrome	0.00028	0.0104	CbGeAlD
Nateglinide—PPARG—vagina—acquired immunodeficiency syndrome	0.000279	0.0104	CbGeAlD
Nateglinide—ABCC4—blood—acquired immunodeficiency syndrome	0.000273	0.0102	CbGeAlD
Nateglinide—KCNJ11—brain—acquired immunodeficiency syndrome	0.000265	0.00988	CbGeAlD
Nateglinide—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000264	0.00984	CbGeAlD
Nateglinide—PPARG—lung—acquired immunodeficiency syndrome	0.000264	0.00982	CbGeAlD
Nateglinide—ORM1—nervous system—acquired immunodeficiency syndrome	0.000261	0.00973	CbGeAlD
Nateglinide—Cough—Stavudine—acquired immunodeficiency syndrome	0.00026	0.00302	CcSEcCtD
Nateglinide—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.000259	0.00301	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.003	CcSEcCtD
Nateglinide—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.003	CcSEcCtD
Nateglinide—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00299	CcSEcCtD
Nateglinide—Cough—Abacavir—acquired immunodeficiency syndrome	0.000257	0.00298	CcSEcCtD
Nateglinide—KCNJ11—lymph node—acquired immunodeficiency syndrome	0.000256	0.00955	CbGeAlD
Nateglinide—Bronchitis—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00296	CcSEcCtD
Nateglinide—Neuropathy peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00293	CcSEcCtD
Nateglinide—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000252	0.00292	CcSEcCtD
Nateglinide—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00292	CcSEcCtD
Nateglinide—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000251	0.00936	CbGeAlD
Nateglinide—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.00291	CcSEcCtD
Nateglinide—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.00025	0.0029	CcSEcCtD
Nateglinide—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.00287	CcSEcCtD
Nateglinide—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00287	CcSEcCtD
Nateglinide—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000247	0.00286	CcSEcCtD
Nateglinide—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.00286	CcSEcCtD
Nateglinide—ABCC8—brain—acquired immunodeficiency syndrome	0.000244	0.0091	CbGeAlD
Nateglinide—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.00283	CcSEcCtD
Nateglinide—PPARG—nervous system—acquired immunodeficiency syndrome	0.000244	0.00909	CbGeAlD
Nateglinide—Neuropathy peripheral—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.00282	CcSEcCtD
Nateglinide—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000243	0.00282	CcSEcCtD
Nateglinide—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.000243	0.00282	CcSEcCtD
Nateglinide—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00281	CcSEcCtD
Nateglinide—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.000241	0.0028	CcSEcCtD
Nateglinide—ABCC4—lung—acquired immunodeficiency syndrome	0.000239	0.00891	CbGeAlD
Nateglinide—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.00275	CcSEcCtD
Nateglinide—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.00274	CcSEcCtD
Nateglinide—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00274	CcSEcCtD
Nateglinide—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000236	0.00273	CcSEcCtD
Nateglinide—SLC15A2—blood—acquired immunodeficiency syndrome	0.000235	0.00877	CbGeAlD
Nateglinide—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.00272	CcSEcCtD
Nateglinide—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000235	0.00875	CbGeAlD
Nateglinide—Back pain—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00271	CcSEcCtD
Nateglinide—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00269	CcSEcCtD
Nateglinide—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00268	CcSEcCtD
Nateglinide—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000229	0.00266	CcSEcCtD
Nateglinide—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00265	CcSEcCtD
Nateglinide—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.00264	CcSEcCtD
Nateglinide—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00263	CcSEcCtD
Nateglinide—SLC15A2—spinal cord—acquired immunodeficiency syndrome	0.000227	0.00845	CbGeAlD
Nateglinide—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.00262	CcSEcCtD
Nateglinide—Tremor—Indinavir—acquired immunodeficiency syndrome	0.000226	0.00262	CcSEcCtD
Nateglinide—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.0026	CcSEcCtD
Nateglinide—SLC16A1—brain—acquired immunodeficiency syndrome	0.000222	0.00828	CbGeAlD
Nateglinide—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000222	0.00257	CcSEcCtD
Nateglinide—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000222	0.00826	CbGeAlD
Nateglinide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000221	0.00256	CcSEcCtD
Nateglinide—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.00256	CcSEcCtD
Nateglinide—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00254	CcSEcCtD
Nateglinide—SLC15A2—vagina—acquired immunodeficiency syndrome	0.000218	0.00813	CbGeAlD
Nateglinide—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.00253	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.00253	CcSEcCtD
Nateglinide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000218	0.00253	CcSEcCtD
Nateglinide—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.00252	CcSEcCtD
Nateglinide—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000215	0.00249	CcSEcCtD
Nateglinide—SLC16A1—lymph node—acquired immunodeficiency syndrome	0.000215	0.008	CbGeAlD
Nateglinide—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000214	0.00249	CcSEcCtD
Nateglinide—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.00248	CcSEcCtD
Nateglinide—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000213	0.00795	CbGeAlD
Nateglinide—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000213	0.00247	CcSEcCtD
Nateglinide—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.00245	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000211	0.00245	CcSEcCtD
Nateglinide—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000211	0.00786	CbGeAlD
Nateglinide—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.00244	CcSEcCtD
Nateglinide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000211	0.00244	CcSEcCtD
Nateglinide—Cough—Indinavir—acquired immunodeficiency syndrome	0.000211	0.00244	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00021	0.00244	CcSEcCtD
Nateglinide—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00021	0.00244	CcSEcCtD
Nateglinide—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00243	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000207	0.0024	CcSEcCtD
Nateglinide—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000207	0.0024	CcSEcCtD
Nateglinide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000207	0.0024	CcSEcCtD
Nateglinide—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000206	0.00239	CcSEcCtD
Nateglinide—SLC15A2—lung—acquired immunodeficiency syndrome	0.000206	0.00769	CbGeAlD
Nateglinide—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00237	CcSEcCtD
Nateglinide—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.00237	CcSEcCtD
Nateglinide—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.00234	CcSEcCtD
Nateglinide—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.00234	CcSEcCtD
Nateglinide—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00234	CcSEcCtD
Nateglinide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000201	0.00233	CcSEcCtD
Nateglinide—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00233	CcSEcCtD
Nateglinide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.0002	0.00232	CcSEcCtD
Nateglinide—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.0002	0.00232	CcSEcCtD
Nateglinide—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000199	0.00231	CcSEcCtD
Nateglinide—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000199	0.00231	CcSEcCtD
Nateglinide—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00231	CcSEcCtD
Nateglinide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000199	0.0023	CcSEcCtD
Nateglinide—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000196	0.00228	CcSEcCtD
Nateglinide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000196	0.00227	CcSEcCtD
Nateglinide—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.00226	CcSEcCtD
Nateglinide—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.00225	CcSEcCtD
Nateglinide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000194	0.00225	CcSEcCtD
Nateglinide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000194	0.00225	CcSEcCtD
Nateglinide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000194	0.00225	CcSEcCtD
Nateglinide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000194	0.00224	CcSEcCtD
Nateglinide—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.00224	CcSEcCtD
Nateglinide—ORM1—lymph node—acquired immunodeficiency syndrome	0.000193	0.00718	CbGeAlD
Nateglinide—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.00223	CcSEcCtD
Nateglinide—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000193	0.00223	CcSEcCtD
Nateglinide—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00223	CcSEcCtD
Nateglinide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000192	0.00223	CcSEcCtD
Nateglinide—SLC15A2—nervous system—acquired immunodeficiency syndrome	0.000191	0.00712	CbGeAlD
Nateglinide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000191	0.00221	CcSEcCtD
Nateglinide—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00221	CcSEcCtD
Nateglinide—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.00221	CcSEcCtD
Nateglinide—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00019	0.0022	CcSEcCtD
Nateglinide—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.00219	CcSEcCtD
Nateglinide—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.00218	CcSEcCtD
Nateglinide—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000188	0.00699	CbGeAlD
Nateglinide—PPARG—brain—acquired immunodeficiency syndrome	0.000187	0.00695	CbGeAlD
Nateglinide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.00216	CcSEcCtD
Nateglinide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000186	0.00216	CcSEcCtD
Nateglinide—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.00215	CcSEcCtD
Nateglinide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000185	0.00688	CbGeAlD
Nateglinide—SLC15A2—central nervous system—acquired immunodeficiency syndrome	0.000184	0.00685	CbGeAlD
Nateglinide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000183	0.00212	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00212	CcSEcCtD
Nateglinide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00212	CcSEcCtD
Nateglinide—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.00211	CcSEcCtD
Nateglinide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000181	0.0021	CcSEcCtD
Nateglinide—PPARG—lymph node—acquired immunodeficiency syndrome	0.00018	0.00671	CbGeAlD
Nateglinide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00018	0.00209	CcSEcCtD
Nateglinide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00209	CcSEcCtD
Nateglinide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000179	0.00208	CcSEcCtD
Nateglinide—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00208	CcSEcCtD
Nateglinide—CYP3A5—blood—acquired immunodeficiency syndrome	0.000179	0.00666	CbGeAlD
Nateglinide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000179	0.00207	CcSEcCtD
Nateglinide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000178	0.00207	CcSEcCtD
Nateglinide—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00207	CcSEcCtD
Nateglinide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000177	0.00205	CcSEcCtD
Nateglinide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000177	0.00205	CcSEcCtD
Nateglinide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000177	0.00205	CcSEcCtD
Nateglinide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000176	0.00656	CbGeAlD
Nateglinide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.00204	CcSEcCtD
Nateglinide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000175	0.00203	CcSEcCtD
Nateglinide—ALB—brain—acquired immunodeficiency syndrome	0.000175	0.00652	CbGeAlD
Nateglinide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000175	0.00203	CcSEcCtD
Nateglinide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.00201	CcSEcCtD
Nateglinide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000173	0.00201	CcSEcCtD
Nateglinide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.00201	CcSEcCtD
Nateglinide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000173	0.002	CcSEcCtD
Nateglinide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000173	0.002	CcSEcCtD
Nateglinide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000172	0.002	CcSEcCtD
Nateglinide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000172	0.002	CcSEcCtD
Nateglinide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.002	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00197	CcSEcCtD
Nateglinide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00017	0.00197	CcSEcCtD
Nateglinide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00197	CcSEcCtD
Nateglinide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00196	CcSEcCtD
Nateglinide—ABCC4—brain—acquired immunodeficiency syndrome	0.000169	0.00631	CbGeAlD
Nateglinide—ALB—lymph node—acquired immunodeficiency syndrome	0.000169	0.0063	CbGeAlD
Nateglinide—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000169	0.00628	CbGeAlD
Nateglinide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.00195	CcSEcCtD
Nateglinide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00194	CcSEcCtD
Nateglinide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.00194	CcSEcCtD
Nateglinide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000167	0.00193	CcSEcCtD
Nateglinide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000167	0.00193	CcSEcCtD
Nateglinide—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000166	0.00618	CbGeAlD
Nateglinide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000164	0.0019	CcSEcCtD
Nateglinide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000164	0.0019	CcSEcCtD
Nateglinide—ABCC4—lymph node—acquired immunodeficiency syndrome	0.000164	0.0061	CbGeAlD
Nateglinide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.00187	CcSEcCtD
Nateglinide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000162	0.00187	CcSEcCtD
Nateglinide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000161	0.00187	CcSEcCtD
Nateglinide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000161	0.00187	CcSEcCtD
Nateglinide—PTGS1—blood—acquired immunodeficiency syndrome	0.000161	0.00599	CbGeAlD
Nateglinide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.00186	CcSEcCtD
Nateglinide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00016	0.00186	CcSEcCtD
Nateglinide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.00186	CcSEcCtD
Nateglinide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00185	CcSEcCtD
Nateglinide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000159	0.00184	CcSEcCtD
Nateglinide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000159	0.00184	CcSEcCtD
Nateglinide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000159	0.00184	CcSEcCtD
Nateglinide—CYP3A5—lung—acquired immunodeficiency syndrome	0.000157	0.00584	CbGeAlD
Nateglinide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.00182	CcSEcCtD
Nateglinide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000156	0.00181	CcSEcCtD
Nateglinide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000156	0.0018	CcSEcCtD
Nateglinide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000155	0.0018	CcSEcCtD
Nateglinide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000155	0.0018	CcSEcCtD
Nateglinide—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000155	0.00577	CbGeAlD
Nateglinide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.00179	CcSEcCtD
Nateglinide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.00178	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.00178	CcSEcCtD
Nateglinide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000154	0.00178	CcSEcCtD
Nateglinide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.00178	CcSEcCtD
Nateglinide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000153	0.00178	CcSEcCtD
Nateglinide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00178	CcSEcCtD
Nateglinide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000153	0.00177	CcSEcCtD
Nateglinide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.00176	CcSEcCtD
Nateglinide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.00176	CcSEcCtD
Nateglinide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000151	0.00175	CcSEcCtD
Nateglinide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000151	0.00175	CcSEcCtD
Nateglinide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00015	0.00174	CcSEcCtD
Nateglinide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.00174	CcSEcCtD
Nateglinide—PTGS1—vagina—acquired immunodeficiency syndrome	0.000149	0.00555	CbGeAlD
Nateglinide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00171	CcSEcCtD
Nateglinide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00171	CcSEcCtD
Nateglinide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00169	CcSEcCtD
Nateglinide—SLC15A2—brain—acquired immunodeficiency syndrome	0.000146	0.00544	CbGeAlD
Nateglinide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.00169	CcSEcCtD
Nateglinide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.00168	CcSEcCtD
Nateglinide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000145	0.00168	CcSEcCtD
Nateglinide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.00168	CcSEcCtD
Nateglinide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.00168	CcSEcCtD
Nateglinide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000145	0.00168	CcSEcCtD
Nateglinide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000143	0.00165	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00165	CcSEcCtD
Nateglinide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00165	CcSEcCtD
Nateglinide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.00164	CcSEcCtD
Nateglinide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000141	0.00164	CcSEcCtD
Nateglinide—SLC15A2—lymph node—acquired immunodeficiency syndrome	0.000141	0.00526	CbGeAlD
Nateglinide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000141	0.00525	CbGeAlD
Nateglinide—PTGS1—lung—acquired immunodeficiency syndrome	0.000141	0.00525	CbGeAlD
Nateglinide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.00163	CcSEcCtD
Nateglinide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00014	0.00162	CcSEcCtD
Nateglinide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.00162	CcSEcCtD
Nateglinide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00162	CcSEcCtD
Nateglinide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000139	0.00517	CbGeAlD
Nateglinide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.00159	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00159	CcSEcCtD
Nateglinide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00158	CcSEcCtD
Nateglinide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00156	CcSEcCtD
Nateglinide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.00156	CcSEcCtD
Nateglinide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00156	CcSEcCtD
Nateglinide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000134	0.005	CbGeAlD
Nateglinide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.00155	CcSEcCtD
Nateglinide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.00155	CcSEcCtD
Nateglinide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.00155	CcSEcCtD
Nateglinide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00154	CcSEcCtD
Nateglinide—CYP2D6—blood—acquired immunodeficiency syndrome	0.000132	0.00492	CbGeAlD
Nateglinide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.00153	CcSEcCtD
Nateglinide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.00152	CcSEcCtD
Nateglinide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.00152	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00151	CcSEcCtD
Nateglinide—PTGS1—nervous system—acquired immunodeficiency syndrome	0.00013	0.00486	CbGeAlD
Nateglinide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00151	CcSEcCtD
Nateglinide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00013	0.00151	CcSEcCtD
Nateglinide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00151	CcSEcCtD
Nateglinide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.0015	CcSEcCtD
Nateglinide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.00148	CcSEcCtD
Nateglinide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.00148	CcSEcCtD
Nateglinide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00146	CcSEcCtD
Nateglinide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00146	CcSEcCtD
Nateglinide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.00146	CcSEcCtD
Nateglinide—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000126	0.00468	CbGeAlD
Nateglinide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00145	CcSEcCtD
Nateglinide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000125	0.00145	CcSEcCtD
Nateglinide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000124	0.00144	CcSEcCtD
Nateglinide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000124	0.00144	CcSEcCtD
Nateglinide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.00143	CcSEcCtD
Nateglinide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.00143	CcSEcCtD
Nateglinide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.00141	CcSEcCtD
Nateglinide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00141	CcSEcCtD
Nateglinide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00139	CcSEcCtD
Nateglinide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00139	CcSEcCtD
Nateglinide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.00137	CcSEcCtD
Nateglinide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.00137	CcSEcCtD
Nateglinide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.00136	CcSEcCtD
Nateglinide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00136	CcSEcCtD
Nateglinide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00136	CcSEcCtD
Nateglinide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000117	0.00136	CcSEcCtD
Nateglinide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00135	CcSEcCtD
Nateglinide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00135	CcSEcCtD
Nateglinide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.00132	CcSEcCtD
Nateglinide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.00131	CcSEcCtD
Nateglinide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.00131	CcSEcCtD
Nateglinide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.0013	CcSEcCtD
Nateglinide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.0013	CcSEcCtD
Nateglinide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.0013	CcSEcCtD
Nateglinide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00129	CcSEcCtD
Nateglinide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.00128	CcSEcCtD
Nateglinide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000109	0.00406	CbGeAlD
Nateglinide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.00126	CcSEcCtD
Nateglinide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00126	CcSEcCtD
Nateglinide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00126	CcSEcCtD
Nateglinide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000107	0.00399	CbGeAlD
Nateglinide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.00124	CcSEcCtD
Nateglinide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00123	CcSEcCtD
Nateglinide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000105	0.00391	CbGeAlD
Nateglinide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.00121	CcSEcCtD
Nateglinide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00121	CcSEcCtD
Nateglinide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.0012	CcSEcCtD
Nateglinide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.0012	CcSEcCtD
Nateglinide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.0012	CcSEcCtD
Nateglinide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000103	0.00385	CbGeAlD
Nateglinide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00117	CcSEcCtD
Nateglinide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.00116	CcSEcCtD
Nateglinide—Rash—Saquinavir—acquired immunodeficiency syndrome	9.99e-05	0.00116	CcSEcCtD
Nateglinide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.98e-05	0.00116	CcSEcCtD
Nateglinide—PTGS1—brain—acquired immunodeficiency syndrome	9.97e-05	0.00371	CbGeAlD
Nateglinide—Nausea—Ritonavir—acquired immunodeficiency syndrome	9.78e-05	0.00113	CcSEcCtD
Nateglinide—PTGS1—lymph node—acquired immunodeficiency syndrome	9.64e-05	0.00359	CbGeAlD
Nateglinide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.00111	CcSEcCtD
Nateglinide—Rash—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.00111	CcSEcCtD
Nateglinide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.52e-05	0.0011	CcSEcCtD
Nateglinide—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.41e-05	0.00109	CcSEcCtD
Nateglinide—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.98e-05	0.00104	CcSEcCtD
Nateglinide—CYP2D6—brain—acquired immunodeficiency syndrome	8.2e-05	0.00305	CbGeAlD
